Acupuncture as an Adjunct Therapy for Cancer Patients; State of the Research Evidence
Presentation by Weidong Lu, MB, MPH, PhD, Lic. Ac.
Weidong Lu, MB, MPH, PhD, Lic. Ac. is an Instructor in Medicine at Harvard Medical School and a lead oncology acupuncturist who practices and conducts acupuncture research in cancer care at the Zakim Center of Dana-Farber Cancer Institute (DFCI). Originally trained as a physician specialized in Chinese Medicine in China (MB, Zhejiang Chinese Medical University, 1983), he has been actively practicing acupuncture for cancer patients at DFCI for over 12 years, both clinically as well as part of NIH-funded clinical trials in acupuncture. Dr. Lu received his MPH from Harvard School of Public Health and his PhD in Integrative Medicine from Beijing University of Chinese Medicine. He is the first recipient of the Bernard Osher Foundation/ The National Center for Complementary and Alternative Medicine (NCCAM) CAM Practitioner Research Career Development Award (K01). He was the co-leader of an NIH-funded acupuncture trial for chemotherapy-induced neutropenia and is the Principal Investigator of an NIH-funded acupuncture trial for dysphagia after chemoradiation therapy in head and neck cancer.
Thursday, November 1, 2012
Brigham and Women’s Hospital
70 Francis Street
*Shapiro Breakout Room
Shapiro Building, 1st Floor
Boston, MA 02115